BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31922440)

  • 1. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma.
    Zhao F; Cao M; Jiang XH; Xie K; Ye SR; Yie SM
    Biomarkers; 2020 Mar; 25(2):149-156. PubMed ID: 31922440
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
    Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma.
    Yie SM; Ye SR; Ma XL; Xie K; Zhang JB; Cao M; He X; Hu ZB; Yang CL; Zhang J; Zeng J
    Br J Cancer; 2016 Dec; 115(12):1555-1564. PubMed ID: 27875523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of plasma anti-TOPO48 autoantibody and blood survivin-expressing circulating cancer cells in patients with early stage endometrial carcinoma.
    Jiang XH; Yao ZY; He X; Zhang JB; Xie K; Chen J; Cao M; Zhang J; Yie SM
    Arch Gynecol Obstet; 2019 Jan; 299(1):229-237. PubMed ID: 30341503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autoantibody against a 48-Kd fragment of human DNA-topoiomerase I in breast cancer: Implication for diagnosis and prognosis, and antibody-dependent cellular cytotoxicity in vitro.
    He X; Jiang XH; Yie KY; Chen J; Zhang JB; Yie SM
    Cell Immunol; 2020 Jan; 347():104007. PubMed ID: 31732123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer.
    Wu WB; Yie SM; Ye SR; Xie K; Zhang JB; Cao M; Chen J; He X; Ma XL; Zhang J
    Ann Thorac Surg; 2018 Jun; 105(6):1664-1670. PubMed ID: 29453962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up.
    Suppiah A; Alabi A; Madden L; Hartley JE; Monson JR; Greenman J
    Int J Colorectal Dis; 2008 Jun; 23(6):595-600. PubMed ID: 18330580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform.
    Garranzo-Asensio M; Guzmán-Aránguez A; Povedano E; Ruiz-Valdepeñas Montiel V; Poves C; Fernandez-Aceñero MJ; Montero-Calle A; Solís-Fernández G; Fernandez-Diez S; Camps J; Arenas M; Rodríguez-Tomàs E; Joven J; Sanchez-Martinez M; Rodriguez N; Dominguez G; Yáñez-Sedeño P; Pingarrón JM; Campuzano S; Barderas R
    Theranostics; 2020; 10(7):3022-3034. PubMed ID: 32194852
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-panel assay of serum autoantibodies in colorectal cancer.
    Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
    Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
    Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
    Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysis.
    Liu S; Tan Q; Song Y; Shi Y; Han X
    Scand J Immunol; 2020 Feb; 91(2):e12829. PubMed ID: 31536647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
    O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
    PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
    Xu S; Huangfu M; Jia X; Song X; Sun B; Lee KH; Liu L; Sun S
    Int J Clin Oncol; 2015 Oct; 20(5):982-8. PubMed ID: 25681877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.